AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2015
May 6, 2015
32163_dirs_2015-05-06_e32766e0-d274-42fc-a0a4-d66b9d6fe618.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2015-05-06
Reporting Person: Duke Barry S (see remarks)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to purchase) | $5.73 | 2025-03-30 | Common Stock (72463) | Direct |
Footnotes
F1: The options vest and become exercisable over a 4-year period commencing on March 30, 2015. Twenty-five percent (25%) of the options vest and become exercisable on March 30, 2016, and the balance of the shares vest in equal monthly installments (rounded up to the nearest whole option) over the remaining three years of the 4-year period.
More from COLLEGIUM PHARMACEUTICAL, INC
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26